Zhengduo Yang

1.6k citations
30 papers · 1.3k indexed · h-index 16
Topics
Cancer-related Molecular Pathways (4 papers)Cytokine Signaling Pathways and Interactions (4 papers)Bioactive Natural Diterpenoids Research (3 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Zhengduo Yang

27 papers receiving 1.3k citations

Peers

Zhengduo Yang
Comparison fields: 5 of 88
  • Molecular Biology 679
  • Oncology 522
  • Cancer Research 229
  • Cell Biology 170
  • Pathology and Forensic Medicine 131
Replace Subhasree Nag with:
Subhasree Nag United States
G. Tim Bowden United States
Donghwa Kim South Korea
Alok Ranjan United States
Kerrie B. Bouker United States
Zehavit Goldberg Israel
Pei‐Ming Yang Taiwan
Junchen Liu China
Yinxue Yang China
Shuo Deng Singapore
Zhengduo Yang relative to Subhasree Nag United States Subhasree Nag's profile →
Citations per field
00.5×
Subhasree Nag · 1×
Citations per year

Countries citing papers authored by Zhengduo Yang

Since Specialization
Citations

This map shows the geographic impact of Zhengduo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengduo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengduo Yang more than expected).

Fields of papers citing papers by Zhengduo Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengduo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengduo Yang. The network helps show where Zhengduo Yang may publish in the future.

Co-authorship network of co-authors of Zhengduo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengduo Yang. A scholar is included among the top collaborators of Zhengduo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengduo Yang. Zhengduo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 3
5 12
6 28
7 56
8 4
9 47
10 130
11 1
12 48
13 46
14 74
15 123
16 79
17 72
18 61
19 6
20 30

About Zhengduo Yang

Zhengduo Yang is a scholar working on Oncology, Pharmacology and Toxicology, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Bioactive Natural Diterpenoids Research (3 papers). The work is most often cited by research in Oncology (522 citations), Toxicology (55 citations) and Cancer Research (229 citations). Zhengduo Yang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Qiang Shen, Jia Zhou, Shiwu Zhang, Ailian Xiong, Yi‐Cheng Shen, Haijun Chen, Chunyong Ding, Yusong Zhang, Dan Zhang and Fei Fei. Their work appears in journals such as Cancer, Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026